Impact of a Low-Dose Combination of Isradipine SRO and Spirapril on Left Ventricular Mass and Left Ventricular Performance in Patients with Hypertension and Left Ventricular Hypertrophy

Author： Pittrow D.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.10, 2002-01, pp. : 667-675

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Left Ventricular Hypertrophy in Hypertension

By  

Heart Drug, Vol. 2, Iss. 5, 2003-01 ,pp. : 251-265

Karger

Access to resources Recommend Favorite

Left Ventricular Hypertrophy in Hypertension

By  

Heart Drug, Vol. 2, Iss. 3, 2002-07 ,pp. : 142-156

Karger

Access to resources Recommend Favorite

Losartan for LIFE in hypertension with left ventricular hypertrophy?

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 1, 2003-01 ,pp. : 115-118

Informa Healthcare

Access to resources Recommend Favorite

Losartan: In the Reduction of Stroke Risk in Patients with Hypertension and Left Ventricular Hypertrophy

By Waugh J.   Keating G.M.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 5, 2003-01 ,pp. : 371-377

Adis International

Access to resources Recommend Favorite

Significance of Fragmented QRS Complexes for Identifying Left Ventricular Hypertrophy in Patients with Hypertension

By Zhang Baowei   Zhen Ya   Shen Dongli   Zhang Guohui  

Annals of Noninvasive Electrocardiology, Vol. 20, Iss. 2, 2015-03 ,pp. : 175-180

Blackwell Publishing

Access to resources Recommend Favorite